Wansbeck General Hospital is a district general hospital based in Ashington, Northumberland, England. It is managed by Northumbria Healthcare NHS Foundation Trust.

There are 384 beds in Wansbeck General Hospital.

During the past decade, Wansbeck General Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wansbeck General Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Institute of Cancer Research, United Kingdom" with 2 trials sponsored, "Medical Research Council" with 2 trials sponsored, "Newcastle-upon-Tyne Hospitals NHS Trust" with 2 trials sponsored and "Ottawa Hospital Research Institute" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wansbeck General Hospital" #1 collaborator was "Northumbria Healthcare NHS Foundation Trust" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "NHS Greater Glasgow and Clyde" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Wansbeck General Hospital" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Heart Failure" (2 trials), "Lung Cancer" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Wansbeck General Hospital" in a lesser frequency.

Most popular intervention types in "Wansbeck General Hospital" are "Drug" (14 trials), "Procedure" (4 trials), "Other" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "adjuvant therapy" (2 trials), "capecitabine" (2 trials), "cyclophosphamide" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wansbeck General Hospital" are 17 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Wansbeck General Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Wansbeck General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wansbeck General Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".